Cargando…
Botulinum toxin use in patients with post-stroke spasticity: a nationwide retrospective study from France
BACKGROUND: Current guidelines recommend intramuscular botulinum toxin type A (BoNT-A) injection as first-line treatment for spasticity, a frequent and impairing feature of various central nervous system (CNS) lesions such as stroke. Patients with spasticity commonly require BoNT-A injections once e...
Autores principales: | Levy, Jonathan, Karam, Pierre, Forestier, Anne, Loze, Jean-Yves, Bensmail, Djamel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10482253/ https://www.ncbi.nlm.nih.gov/pubmed/37681005 http://dx.doi.org/10.3389/fneur.2023.1245228 |
Ejemplares similares
-
Trends in Botulinum Toxin Use among Patients with Multiple Sclerosis: A Population-Based Study
por: Bensmail, Djamel, et al.
Publicado: (2023) -
Botulinum Toxin Modulates Posterior Parietal Cortex Activation in Post-stroke Spasticity of the Upper Limb
por: Veverka, Tomáš, et al.
Publicado: (2019) -
Constraint-Induced Movement Therapy Combined With Botulinum Toxin for Post-stroke Spasticity: A Systematic Review and Meta-Analysis
por: Nasb, Mohammad, et al.
Publicado: (2021) -
Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study
por: Baccouche, Ines, et al.
Publicado: (2022) -
A PRACTICAL GUIDE TO OPTIMIZING THE BENEFITS OF POST-STROKE SPASTICITY INTERVENTIONS WITH BOTULINUM TOXIN A: AN INTERNATIONAL GROUP CONSENSUS
por: FRANCISCO, Gerard E., et al.
Publicado: (2020)